Many studies that tested whether the polymorphisms in the promoter region of IL-10 gene are associated with hepatocellular carcinoma or colorectal cancer have shown controversial and inconclusive results8, 11, 12, 13, at least in part because these studies are individually underpowered and involve different ethnic groups. The gene discussed is IL10; the disease is hepatocellular carcinoma.